Lunai Bioworks LNAI
NASDAQ LNAI
$1.30 -0.08 (-5.80%)
At close: Oct 2, 2026 · 4:00 PM EDT

Lunai Bioworks (LNAI) Asset Writedowns and Impairment (2023 - 2025)

Updated

Lunai Bioworks (LNAI) recorded Asset Writedowns and Impairment of $170.42 million in fiscal Q4 2025 (quarter ended Jun 30, 2025).

Analysis

Lunai Bioworks (LNAI) Asset Writedowns and Impairment (2023 - 2025) Analysis & Trends

Starting with fiscal Q4 2023, Lunai Bioworks' Asset Writedowns and Impairment history includes 4 quarters.

  • Across earlier fiscal years, Asset Writedowns and Impairment came in at $42.61 million in FY2024 (+124.7%) and $18.96 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Lunai Bioworks 4.06 Mn -690,718.65 20,942.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 170.42 Mn
Sep 30, 2024 47.61 Mn
Mar 31, 2024 42.61 Mn
Jun 30, 2023 18.96 Mn
API Access

Lunai Bioworks Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=LNAI&period=max&api_key=YOUR_API_KEY